John Maraganore (Scott Eisen/Bloomberg via Getty Images)

John Maraganore want­ed to be­come a biotech grand­dad af­ter leav­ing Al­ny­lam. With his new role at RTW, it looks like he got his wish

On his way out of Al­ny­lam, out­go­ing CEO John Maraganore, who had led the biotech through thick and thin for 19 years, said late last year he want­ed to ad­vise new biotech com­pa­nies in the grand­fa­ther phase of his ca­reer.

“It’s like a grand­fa­ther, right? You get the ben­e­fit of lov­ing your grand­chil­dren, but not hav­ing to take care of them all the time,” Maraganore said at the time. “I want to be a grand­dad.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.